about
Ex vivo cytosolic delivery of functional macromolecules to immune cellsA vector-free microfluidic platform for intracellular deliveryCombinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primatesSize- and shape-dependent foreign body immune response to materials implanted in rodents and non-human primates.Neutrophil Responses to Sterile Implant MaterialsCRISPR-Cas9 knockin mice for genome editing and cancer modelingGene delivery properties of end-modified poly(beta-amino ester)s.Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceIn vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weightRational design of a biomimetic cell penetrating peptide library.Effect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscleCorrigendum: Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates.Bioinspired controlled release of CCL22 recruits regulatory T cells in vivoIn vivo compatibility of graphene oxide with differing oxidation statesDendrimer-Inspired Nanomaterials for the in Vivo Delivery of siRNA to Lung Vasculature.Controlled release formulations of IL-2, TGF-β1 and rapamycin for the induction of regulatory T cells.Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes.Supramolecular PEGylation of biopharmaceuticalsEfficacy and immunogenicity of unmodified and pseudouridine-modified mRNA delivered systemically with lipid nanoparticles in vivo.Plasma membrane recovery kinetics of a microfluidic intracellular delivery platform.Protein bioactivity and polymer orientation is affected by stabilizer incorporation for double-walled microspheres.Colony stimulating factor-1 receptor is a central component of the foreign body response to biomaterial implants in rodents and non-human primatesDelivery of rapamycin to dendritic cells using degradable microparticles.Frontline Science: Splenic progenitors aid in maintaining high neutrophil numbers at sites of sterile chronic inflammation.Microparticulate systems for targeted drug delivery to phagocytes.Synthesis and Biological Evaluation of Ionizable Lipid Materials for the In Vivo Delivery of Messenger RNA to B Lymphocytes.Optimized peptide based inhibitors targeting the dihydrofolate reductase pathway in cancer.Porous calcium phosphate-poly (lactic-co-glycolic) acid composite bone cement: A viable tunable drug delivery system.Rapid Optimization of Gene Delivery by Parallel End-modification of Poly(β-amino ester)sPatchy, anisotropic microspheres with soft protein isletsCorrigendum: Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent miceA retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cellsInjectable Polymer-Nanoparticle Hydrogels for Local Immune Cell RecruitmentDisparate effects of PEG or albumin based surface modification on the uptake of nano- and micro-particlesA Composite of Hyaluronic Acid-Modified Graphene Oxide and Iron Oxide Nanoparticles for Targeted Drug Delivery and Magnetothermal Therapy
P50
Q21131808-37363FDF-9E05-4B12-81BB-0B5DB7093F8BQ24623995-750C370B-BF33-4E9B-AE9A-9F36F2990744Q27313644-E7FB0D56-64E6-4FE4-B2A0-9DA4F8BCE553Q27314755-161111CF-95A1-47B0-8B1D-FD9150032B85Q27318618-BA159870-C88E-4A5B-AD31-FC1B6D198E1DQ30607892-D08B80C5-5509-4CF4-91AA-640CB7107D66Q33302303-2EDAB629-62A8-4378-A307-E07A63DAEB32Q34045963-3DFF8696-5C29-4AB2-AB1C-04E26740577AQ34393539-0754E9A3-33C7-4042-80BE-F87E89BDD559Q34991955-F41D5EE7-A9EC-4A8B-9F69-224C3538E905Q35943638-37809421-33F0-4088-A204-EBA8CAD1C8B7Q36047095-562842A5-4F9C-403B-A63D-E9CB5B6FC783Q36379675-4204F3E4-C53F-4203-8A04-EDFA2B79D2BEQ36779229-48282A0F-287D-47C5-8DDA-50F6F540AD8AQ36781516-ECB5F5FD-4E16-4368-9853-130C79C5038EQ36998551-35A9EFD4-CDCA-42F6-8E04-1D0074DDE2DBQ37319692-7505D266-B7E4-4441-859E-D1A535CF90C6Q37515001-45A56971-3D28-4852-9734-E3F849DDAA98Q37607987-50E82B3E-3E64-4CF5-9C70-77C7A7427EF0Q37666064-FFE70E5A-11CB-40AA-9D9D-6A73A59DC799Q39947357-6EFAE5D1-BE0E-459C-9F11-8D9C35C80FAFQ41716521-67C7126C-9F25-41F6-B7F8-06CB4E7C291DQ41842968-1E207AC5-45B8-4F9B-8C84-E48F80F44B1BQ42419719-FCB18185-85EA-41B9-97ED-3E681344F644Q42862823-54514888-EBB3-4D92-AFC5-5FA27C86F26AQ47954152-E38086EA-99D9-429F-B996-0385794FC8DAQ49912857-6BF60DCD-6F0B-4E27-9FFC-055493F6460FQ51612484-78EAAA6F-09B1-4ACF-9A8E-74D9A0DFB40AQ58828292-80D1491E-2FEA-4172-8E83-6AA5CFAB850AQ84646829-A6037556-5370-4A15-A9B9-3FB702AC91EAQ89131757-49E11620-5CA9-484B-8FEB-E4DF57560F8FQ90776862-180D145A-4E45-40CB-B5EB-DE452331F4DEQ91088072-6C1522ED-743B-4C69-BBE5-CD91257B84ECQ91137746-79D96EE7-895B-4004-A3B2-80091BCDA3E4Q92945908-F566EDBB-AC58-4401-ACF6-566F36A19C7B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Siddharth Jhunjhunwala
@ast
Siddharth Jhunjhunwala
@en
Siddharth Jhunjhunwala
@es
Siddharth Jhunjhunwala
@nl
Siddharth Jhunjhunwala
@sl
type
label
Siddharth Jhunjhunwala
@ast
Siddharth Jhunjhunwala
@en
Siddharth Jhunjhunwala
@es
Siddharth Jhunjhunwala
@nl
Siddharth Jhunjhunwala
@sl
altLabel
S Jhunjhunwala
@en
prefLabel
Siddharth Jhunjhunwala
@ast
Siddharth Jhunjhunwala
@en
Siddharth Jhunjhunwala
@es
Siddharth Jhunjhunwala
@nl
Siddharth Jhunjhunwala
@sl
P1053
K-1526-2013
P106
P1153
16642809500
P21
P31
P3829
P496
0000-0001-8046-2288
P569
2000-01-01T00:00:00Z